Efficacy and safety of Intravitreal Aflibercept Vs Verteporfin Photodynamic Therapy in a Caucasian Population with Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial

Efficacy and safety of Intravitreal Aflibercept Vs Verteporfin Photodynamic Therapy in a Caucasian Population with Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial

Rufino Silva, Luis Arias, Sandrina Nunes, Claudia Farinha, Rita Coimbra, João P Maques, Maria L Cachulo, João Figueira, Patricia Barreto, Maria H Madeira, Isabel Pires, João C Sousa, Laura Distefano, Paulo Rosa, Ângela Carneiro, Sara Vaz-Pereira, Angelina Meireles, Francisco Cabrera, Anniken Bures, Luís Mendonça, Alvaro Fernandez-Vega Sanz, Sandra Barrão, Adrian Koh, Chui Ming Gemmy Cheung, José G Cunha-Vaz, Joaquim Murta, EVICR.net ATLANTIC Study Group

Ophthalmologica . 2021 Jul 13. doi: 10.1159/000518235.

2021

https://www.karger.com/Article/Abstract/518235

Challenges, facilitators and barriers to screening study participants in early disease stages-experience from the MACUSTAR study

Challenges, facilitators and barriers to screening study participants in early disease stages-experience from the MACUSTAR study

Terheyden JH, Behning C, Lüning A, Wintergerst L, Basile PG, Tavares D, Melício BA, Leal S, Weissgerber G, Luhmann UFO, Crabb DP,Tufail A, Hoyng CB, Berger M, Schmid M, Silva R , Martinho CV, Cunha-Vaz J, Holz FG, Finger RP, MACUSTAR consortium

BMC Med Res Methodol. 2021 Mar 17;21(1):54. doi: 10.1186/s12874-021-01243-8.

2021

Current management of patients with RPE65 mutation-associated inherited retinal degenerations (IRDs) in Europe. Results of a multinational survey by the European Vision Institute Clinical Research Network EVICR.net

Current management of patients with RPE65 mutation-associated inherited retinal degenerations (IRDs) in Europe. Results of a multinational survey by the European Vision Institute Clinical Research Network EVICR.net

Lorenz B, Tavares J, van den Born LI, Marques JP, Scholl HPN, The EVICR.net Group

2021 Mar 8. doi: 10.1159/00051568

2021

Real-world intensive safety monitoring of biosimilars rituximab and trastuzumab in a Portuguese oncology hospital

Real-world intensive safety monitoring of biosimilars rituximab and trastuzumab in a Portuguese oncology hospital

Mendes D, Abrantes J, Rigueiro G, Pais AF, Penedones A, Alves C, Batel Marques F.

J Oncol Pharm Pract. 2020 Sep 16;1078155220957079. doi: 10.1177/1078155220957079.

2020

https://journals.sagepub.com/doi/10.1177/1078155220957079?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

Emerging Trends in Nanomedicine for Improving Ocular Drug Delivery: Light-Responsive Nanoparticles, Mesoporous Silica Nanoparticles, and Contact Lenses

Emerging Trends in Nanomedicine for Improving Ocular Drug Delivery: Light-Responsive Nanoparticles, Mesoporous Silica Nanoparticles, and Contact Lenses

Rodrigues F, Campos A, Martins J. Ambrosio AF, Campos EJ.

ACS Biomater. Sci. Eng. 2020 https://doi.org/10.1021/acsbiomaterials.0c01347.

2020

https://pubs.acs.org/doi/pdf/10.1021/acsbiomaterials.0c01347

Swept source OCTA quantification of capillary closure predicts ETDRS severity staging of NPDR

Swept source OCTA quantification of capillary closure predicts ETDRS severity staging of NPDR

Santos T, Lewis W, Santos AR, Marques IP, Kubach S, Mendes L, Sisternes L, Madeira MH, Durbin MK, Cunha-Vaz J.

British Journal of Opthalmology2020 Dec 22:bjophthalmol-2020-317890. doi: 10.1136/bjophthalmol-2020-317890.

2020

https://bjo.bmj.com/content/bjophthalmol/early/2020/12/22/bjophthalmol-2020-317890.full.pdf